CMMI policy shifts in election year

Medicare payment policy is not usually campaign-trail material. But CMMI — the Center for Medicare & Medicaid Innovation — is one of the few places where an administration can move fast on health care without waiting for Congress. That is why it matters now. The Trump administration is using CMMI to push a new set of models around chronic care, drug pricing, behavioral health, rural accountable care, and lifestyle-medicine ideas tied to its broader “Make America Healthy Again” agenda. (natlawreview.com) ### What is CMMI, exactly? CMMI is Medicare’s in-house pilot shop. The Affordable Care Act created it to test payment and care-delivery models in Medicare, Medicaid, and CHIP, then expand the ones that lower spending or improve quality. In plain English, it is where CMS experiments with new ways to pay doctors, hospitals, plans, and care organizations. (natlawreview.com) ### What changed this week? The immediate news is not one giant rule. It is the pace and posture. A new legal and policy readout published April 29 said CMS is now pursuing roughly 35 models and is treating CMMI as a primary vehicle for administration priorities. That lines up with what CMS has been doing in public — releasing applications for the (natlawreview.com)ginning March 13. (natlawreview.com) ### Why does that matter more in an election year? Because CMMI sits in a weirdly powerful lane. Congress does not have to pass a new law for these tests to start reshaping incentives. If you are a hospital, physician group, ACO, Medicaid agency, or Medicare Part D plan, a “pilot” can still force real operational choices — staffing, reporting, contracting, downside risk, and technology investment. In an election year, that turns model design into politics fast. (natlawreview.com) ### What is the administration trying to do with it? The strategy changed in a visible way last year. CMS recast the Innovation Center around three pillars: evidence-based prevention, patient empowerment, and choice and competition, all under a stated principle of protecting taxpayers. That is a noticeable shift away from the older framing around h(natlawreview.com)ogical accent and a stronger insistence that models show financial discipline. (cms.gov) ### Which models best show the shift? Three examples tell the story. BALANCE tries to lower the cost of select GLP-1 weight-loss drugs in Medicare Part D and Medicaid. LEAD aims to pull more small, rural, and independent providers into ACO-style arrangements. MAHA ELEVATE offers up to 30 three-year cooperative agreements totaling as much as $100 million for evidence-based lifestyle or functional-medicine programs that supplement conventional care. (cms.gov) ### So why is CMMI under scrutiny? Because the scorecard is awkward. CBO said CMMI increased net federal spending by $5.4 billion from 2011 to 2020, with $7.9 billion spent operating models and only $2.6 billion in benefit savings. CBO also projected CMMI would increase, not reduce, federal spending over 2021 to 2030. That does not mean every model failed. It does mean critics now have a c(cms.gov)ved money. (cbo.gov) ### What are hospitals and plans watching for now? They are watching less for speeches than for design details — who must participate, who can opt in, how benchmarks are set, whether downside risk grows, and which models eventually become permanent. A model can look niche on paper and still rewrite the business case for a rural practice, a health plan, or a hospital system. That is the real election-year story here. (([cbo.gov)/election-year-politics-and-policy-cmmi-what-stakeholders-can-expect)) ### Bottom line? CMMI is becoming a faster, more overt policy tool. If these models stick, they could shape 2026 incentives well before voters ever hear the phrase “Innovation Center.” (natlawreview.com)